NewGenIvf Group Limited (NASDAQ:NIVF) Stock Short Interest Report for October

NewGenIvf Group Limited (NASDAQ:NIVF) was the target of a large decrease in short interest in October. As of October 30th, there was short interest totaling 125,342 shares, a decrease of 94.9% from the October 15th total of 2,470,389 shares. Based on an average daily trading volume, of 934,259 shares, the days-to-cover ratio is presently 0.1 days. Approximately 16.5% of the shares of the company are short sold.

Analyst Ratings Changes

Several analysts recently commented on NIVF shares. Wall Street Zen cut NewGenIvf Group to a “strong sell” rating in a research report on Saturday, October 24th. Weiss Ratings reiterated a “sell (d)” rating on shares of NewGenIvf Group in a research report on Monday, November 2nd. One equities research analyst has rated the stock with a Sell rating. According to MarketBeat.com, the stock currently has an average rating of “Sell”.

NewGenIvf Group Stock Down 30.0%

Shares of NIVF stock traded down $0.12 during midday trading on Tuesday, reaching $0.28. 505,898 shares of the company were exchanged, compared to its average volume of 414,765. NewGenIvf Group has a 12 month low of $0.27 and a 12 month high of $8,266.75. The company’s 50 day moving average price is $12.77 and its two-hundred day moving average price is $358.26.

NewGenIvf Group (NASDAQ:NIVF) last posted its quarterly earnings data on Wednesday, October 7th. The company reported ($111.54) earnings per share (EPS) for the quarter, missing the consensus estimate of $581.76 by ($693.30). The firm had revenue of $0.96 million for the quarter, compared to analyst estimates of $20.10 million. On average, analysts forecast that NewGenIvf Group will post 1365.44 earnings per share for the current fiscal year.

About NewGenIvf Group

NewGenIvf Group Limited (NASDAQ:NIVF) is a fertility-services company focused on assisted reproductive technology and related medical care. Through its NewGen IVF operations, the company provides services intended to help individuals and couples pursue pregnancy, including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), intrauterine insemination (IUI), fertility assessments and fertility-preservation procedures. Its service offering also includes egg and sperm freezing, embryo-related services, genetic testing and donor-program support, subject to applicable medical and regulatory requirements.